Date: Nov 15, 2013 Source: MDA (
click here to go to the source)
An MDA-funded company's next generation of molecular-biology tools offers researchers greater accuracy in cellular analysis, while providing a tool for learning more about the human body through genomics.
Translume, Inc. (Ann Arbor, MI), a leading developer of microfluidic chips for biomedical research, has upgraded its offerings to include new components such as three-dimensional sheath flow cells and microfluidic chips with integrated fiber sensors.
All of Translume chips are laser-etched to provide tiny channels to route chemical reactants, but the upgraded versions should enable greater functionality—bringing benefits such as improved hydrodynamic features and easier integration into analytical instruments that are commonly used in the fields of genomics and particle counting. Translume already offers its enhanced chips for sale.
MDA first funded Translume through a 2004 STTR Phase I award to develop technology related to laser etching and micromachining.
Translume is a developer and manufacturer of glass machining technologies. The company specializes in producing microfluidic tools for use in biomedical research.
